My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.731 -0.089 (-4.87%)
Streaming Delayed Price Updated: 11:14 AM EDT, Oct 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
35 36 Next >
3 Market ETF Stocks to Buy This Week on Fed Jitters
The bears have two major tailwinds and the Fed is one. Here are 3 ETF stocks to buy into a potential relief rally after the event blows over. 
Via InvestorPlace
Ocugen Is Two Strikes in With a Third in the Books
Ocugen failed to get energency use authorization for pediatric use of Covaxin. OCGN stock has tanked as a result. 
Via InvestorPlace
68 Biggest Movers From Friday
Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares jumped 101.8% to close at $40.77 on Friday after jumping 39% on Thursday. Mexco Energy Corporation (NYSE: MXC... 
Via Benzinga
Why Is Ocugen (OCGN) Stock Down Today?
Shares of OCGN stock are in the red after the company's Covaxin Covid-19 vaccine was declined EUA by the FDA. Here's what you should know. 
Via InvestorPlace
Why Ocugen Shares Are Falling
Ocugen Inc (NASDAQ:OCGN) shares are trading lower by 22.8%... 
Via Benzinga
Is Sweetgreen Stock a Buy After Earnings? 3 Analysts Weigh In on SG.
Sweetgreen (SG) stock is rising as we check it with analysts following the fast-casual restaurants' most recent earnings report. 
Via InvestorPlace
43 Stocks Moving In Friday's Mid-Day Session
Gainers VEON Ltd. (NASDAQ: VEON) rose 45.6% to $0.3830 after dropping 41% on Thursday. Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 45.2% to $29.33 after... 
Via Benzinga
Is BABA Stock a Buy? 3 Analysts Weigh In on Alibaba.
Alibaba (BABA) stock is in the news lately with the company's shares slipping and we're seeing what experts have to say. 
Via InvestorPlace
Ocugen Latest News: What OCGN Stock Investors Need to Know About the FDA’s Covaxin Rejection
Ocugen (OCGN) stock is falling hard on Friday after the FDA rejected its Emergency Use Authorization request for Covaxin. 
Via InvestorPlace
Recap: Ocugen Q4 Earnings
Ocugen (NASDAQ:OCGN) reported its Q4 earnings results on Friday, February 25, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Also check... 
Via Benzinga
Why Ocugen Shares Are Falling
Ocugen Inc (NASDAQ:OCGN) shares are trading lower by 19.6%... 
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; U.S. Economy Adds 678,000 Jobs
U.S. stocks opened on a downbeat note this morning following the release of weekly jobless claims data. Following the market opening Friday, the Dow traded down 1.29% to 33,360.18... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Statera BioPharma (NASDAQ:STAB) stock rose 23.6% to $0.9 during Friday's pre-market session. The company's market cap stands at $32.4 million. InVivo... 
Via Benzinga
FDA Denies Pediatric EUA To Ocugen For Bharat Biotech's COVID-19 Vaccine Covaxin
The FDA has declined to issue an Emergency Use Authorization (EUA) for Covaxin for active immunization to prevent COVID-19 in individuals 2 to 18 years of age. Ocugen... 
Via Benzinga
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck's Keytruda Evaluated In Combination With Microbiome Therapeutic In... 
Via Benzinga
Looking Into Ocugen Inc's Recent Short Interest
Ocugen Inc's (NASDAQ:OCGN) short percent of float has risen 8.35% since its last report. The company recently reported that it has 54.94 million shares sold short, which is 30.23... 
Via Benzinga
Earnings Scheduled For February 25, 2022
Companies Reporting Before The Bell • ACM Research (NASDAQ:ACMR) is estimated to report quarterly earnings at $0.64 per share on revenue of $89.53 million. •... 
Via Benzinga
63 Biggest Movers From Yesterday
Gainers Tenneco Inc. (NYSE: TEN) shares surged 93.9% to close at $19.35 on Wednesday after the company announced it will be acquired by Apollo Funds. Tenneco also reported a... 
Via Benzinga
Is OCGN Stock a Buy After 20% Plunge? One Analyst Thinks It Can Go to $15.
Ocugen is down more than 20% after announcing a common stock offering. Could this possibly present a buying opportunity for OCGN stock? 
Via InvestorPlace
7 Popular Stocks That Pros Agree You Should Punt From Your Portfolio
These stocks to sell run the gamut in terms of industry, but they all have one thing in common: the pros think they ought to be sold. 
Via InvestorPlace
40 Stocks Moving In Wednesday's Mid-Day Session
Gainers Tenneco Inc. (NYSE: TEN) shares jumped 94.1% to $19.38 after the company announced it will be acquired by Apollo Funds. Tenneco also reported a Q4 loss of $0.11 per share... 
Via Benzinga
Vertiv News: Why Is VRT Stock Plunging Today?
Vertiv (VRT) stock isn't doing so hot on Wednesday following the release of the manufacturing company's earnings report for Q4 2021. 
Via InvestorPlace
OCGN Stock Alert: The $50 Million Reason Ocugen Is Tanking Today
After rising sharply in recent days, Ocugen shares are again falling on news that the company is issuing $50 million of common stock. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Revelation Biosciences (NASDAQ:REVB) stock increased by 29.9% to $2.0 during Wednesday's pre-market session. The market value of their outstanding shares is at... 
Via Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase... 
Via Benzinga
23 Stocks Moving in Wednesday's Pre-Market Session
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 64.9% to $2.54 in pre-market trading after gaining around 5% on Tuesday. Roth Capital recently initiated coverage on the... 
Via Benzinga
73 Biggest Movers From Yesterday
Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Revelation Biosciences (NASDAQ:REVB 
Via Benzinga
Ocugen Is Too Uncertain as Time Runs Out for Covaxin’s Approval
Ocugen's path to entry in the North American market is highly uncertain, making OCGN stock a remarkably risky bet at this point. 
Via InvestorPlace
Mid-Afternoon Market Update: US Stocks Pare Losses; Meritor Shares Spike Higher
U.S. stocks pared back some losses toward the end of trading on Tuesday. Russian President Vladimir Putin said he would recognize the independence of two Russian-led... 
Via Benzinga
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.